Predictors of respiratory failure after thoracic surgery: a retrospective cohort study with comparison between lobar and sub-lobar resection
Aldo Pezzuto(Unknown), Erino Angelo Rendina(University of Zurich), Giulio Guerrieri(Azienda Ospedaliera Sant'Andrea), S. CASTELLI(Azienda Ospedaliera Sant'Andrea), Giuseppe Tonini(Campus Bio Medico University Hospital), Massimo Ciccozzi(International Organization for Migration), Alberto Rícci(Azienda Ospedaliera Sant'Andrea), Maria Chianese(University of Trieste), Beatrice Trabalza Marinucci(Azienda Ospedaliera Sant'Andrea), Michela D’Ascanio(Azienda Ospedaliera Sant'Andrea)
Cited by 21
Related Papers
FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE study
|The Lancet Oncology|2015|1.1k
Initial Therapy with FOLFOXIRI and Bevacizumab for Metastatic Colorectal Cancer
|New England Journal of Medicine|2014|1.1k
Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer
|Annals of Oncology|2021|724
Galectin-3: One Molecule for an Alphabet of Diseases, from A to Z
|International Journal of Molecular Sciences|2018|370